Sign in
4

Changes in Ownership

VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-25-000201

EVP, Chief Scientific Officer sold 52 shares at $424.69 ($22,084)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ALTSHULER DAVID · EVP, Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-05-15 Sale : show line 1 in the form 10b5-1 −52 $424.69 $22,084 23,281 D
Open-market sales · 52 sh · avg $424.69 · $22,084
Loading xslF345X05/wk-form4_1747688856.xml…